ImpediMed Limited
IPDQF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $111,772,534 | $116,313,185 | $195,330 | $234,563 |
| - Cash | $22,183 | $17,693 | $24,632 | $36,905 |
| + Debt | $14,491 | $1,046 | $1,143 | $1,273 |
| Enterprise Value | $111,764,842 | $116,296,538 | $171,841 | $198,931 |
| Revenue | – | $6,008 | $5,535 | $4,784 |
| % Growth | – | 8.5% | 15.7% | – |
| Gross Profit | – | $5,291 | $4,853 | -$7,829 |
| % Margin | – | 88.1% | 87.7% | -163.6% |
| EBITDA | – | -$9,373 | -$10,830 | -$5,295 |
| % Margin | – | -156% | -195.7% | -110.7% |
| Net Income | – | -$11,146 | -$10,072 | -$9,718 |
| % Margin | – | -185.5% | -182% | -203.1% |
| EPS Diluted | – | 0 | -0.005 | -0.005 |
| % Growth | – | 100% | 0% | – |
| Operating Cash Flow | – | -$7,275 | -$11,015 | -$6,774 |
| Capital Expenditures | – | $0 | -$2,866 | -$1,672 |
| Free Cash Flow | – | -$7,275 | -$13,881 | -$8,446 |